The shift from physician-owned to corporate-owned care has drawn intense scrutiny due to several documented trends:
This feature explores the evolving landscape of private equity (PE) acquisitions in the medical sector as of 2026. private equity firms buying medical practices
: While primary care was the early focus, firms are now aggressively targeting high-margin specialties including dermatology, ophthalmology, gastroenterology, and orthopedics. The shift from physician-owned to corporate-owned care has
After a period of stabilization, healthcare private equity deal value reached an estimated , surpassing previous highs. This momentum has carried into 2026, driven by a massive "dry powder" stockpile and a pivot toward technology-enabled assets like AI-based telehealth and revenue cycle management. This momentum has carried into 2026, driven by
Physicians are increasingly seeking PE partnerships to navigate a complex modern landscape:
: PE provides the funds needed to upgrade electronic medical record (EMR) systems and invest in advanced diagnostic tools.